Related references
Note: Only part of the references are listed.Epidermal growth factor receptor inhibitors in the treatment of lung cancer: reality and hopes
Paul Wheatley-Price et al.
CURRENT OPINION IN ONCOLOGY (2008)
Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry
Ferenc Pinter et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Evidence for efficient phosphorylation of EGFR and rapid endocytosis of phosphorylated EGFR via the early/late endocytic pathway in a gefitinib-sensitive non-small cell lung cancer cell line
Yukio Nishimura et al.
MOLECULAR CANCER (2008)
Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: Implications for cancer therapy
Elizabeth S. Henson et al.
CELLULAR SIGNALLING (2006)
Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels
Barbara A. Helfrich et al.
CLINICAL CANCER RESEARCH (2006)
Expression of Ku80 correlates with sensitivities to radiation in cancer cell lines of the head and neck
Hyo Won Chang et al.
ORAL ONCOLOGY (2006)
Epithelial growth factor receptor status in primary and recurrent ovarian cancer
S Stadlmann et al.
MODERN PATHOLOGY (2006)
Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer
G Hudelist et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Epidermal growth factor receptor (EGFR) signaling in cancer
N Normanno et al.
GENE (2006)
Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas
Christine H. Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Autocrine, paracrine and juxtacrine signaling by EGFR ligands.
AB Singh et al.
CELLULAR SIGNALLING (2005)
Epidermal growth factor receptor mutations in non-small-cell lung cancer:: Implications for treatment and tumor biology
PA Jänne et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Ligand-induced, p38-dependent apoptosis in cells expressing high levels of epidermal growth factor receptor and ErbB-2
O Tikhomirov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: A southwest oncology group study
G Arpino et al.
CLINICAL CANCER RESEARCH (2004)
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
D Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
EGF family of growth factors: Essential roles and functional redundancy in the nerve system
CJ Xian et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Lack of expression of EGF and TGF-α in the fetal mouse alters formation of prostatic epithelial buds and influences the response to TCDD
BD Abbott et al.
TOXICOLOGICAL SCIENCES (2003)
Epidermal growth factor receptor in non-small-cell lung carcinomas:: Correlation between gene copy number and protein expression and impact on prognosis
FR Hirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Expression of the HERI-4 family of receptor tyrosine kinases in breast cancer
CJ Witton et al.
JOURNAL OF PATHOLOGY (2003)
Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy
E Raymond et al.
DRUGS (2000)
Share Paper
